The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study-Reference-Cited by-同舟云学术

The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study

Published:2023-04 Issue: Volume:50 Page:57-60
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Fischer Stefanie,Rothermundt Christian,Stalder Odile,Terbuch Angelika,Hermanns Thomas,Zihler Deborah,Müller Beat,Fankhauser Christian D.,Hirschi-Blickenstorfer Anita,Seifert Bettina,Kluth Luis Alex,Ufe Mark-Peter,Mingrone Walter,Templeton Arnoud J.,Fischer Natalie,Rothschild Sacha,Woelky Regina,Gillessen Silke,Cathomas Richard

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors;Gilligan;J Clin Oncol,2010

2. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors;Morris;J Urol,2000

3. False positive beta-human chorionic gonadotropin in testicular cancer;Mohler;Urology,1987

4. Increased human chorionic gonadotropin due to hypogonadism after treatment of a testicular seminoma;Lempiäinen;Clin Chem,2007

5. Pitfalls in management of patients with germ cell tumors and slight elevation of serum α-fetoprotein;Albany;J Clin Oncol,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS);European Urology Open Science;2024-10

2. Hodentumor – welche Vorteile bringt der neue Tumormarker microRNA-371a-3p (M371-Test);Aktuelle Urologie;2024-08-12

3. Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers;Cancers;2024-03-31

4. Advances in the application of metal oxide nanozymes in tumor detection and treatment;Colloids and Surfaces B: Biointerfaces;2024-03

5. Hodenkrebs: neue Entwicklungen, Molekularpathologie und aktuelle Forschungsschwerpunkte;Die Pathologie;2023-11-17